NCT05616611

Brief Summary

Background: The relationship between immobilization and localized osteoporosis is well documented in chronic stroke patients. Hemiparetic patients are predisposed to fractures and usual activity impairment due to a considerable loss of bone density. A serious health care challenge is finding ways to reduce osteoporosis and associated fractures among stroke survivors. This study aimed to compare the effects of HILT and ESWT in treating osteoporosis and its consequences in hemiparetic patients. Patients and Methods: A randomized controlled trial was performed at the Faculty of Physical Therapy Outpatient Clinic, Cairo University. One hundred and twenty hemiplegic patients with osteoporosis of both sexes were chosen randomly. They were randomly classified into three equal groups (n=40 in each group). The control group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise). The high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy. The shock wave (SW) group received the same intervention as the control group in addition to shock wave therapy. The three groups received an intervention that lasted 3 sessions/week for 12 weeks). All groups were assessed before and after therapy (3 months) for the degree of pain, which was evaluated by visual analog scale (VAS), fall risk assessment (overall stability index and Short Form of Berg Balance Scale (SFBBS)), and Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 1, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
Last Updated

November 15, 2022

Status Verified

November 1, 2022

Enrollment Period

5 months

First QC Date

November 1, 2022

Last Update Submit

November 7, 2022

Conditions

Keywords

Shock WaveHigh intensity laserOsteoporosisHemiplegia

Outcome Measures

Primary Outcomes (3)

  • Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41)

    Quality of Life Questionnaire of the European Foundation for Osteoporosis

    12 weeks

  • Pain intensity

    Visual analogue scale, a scale of 10 poi to 0 represent no pain at all and 10 represent the worst pain

    12 weeks

  • fall risk assessment

    Short Form of Berg Balance Scale ,(SFBBS) ranged from 0 poor balance to 28 good balance.consisted of 7 items each item has grades from 1 poor balance to 4 good balance

    12 weeks

Study Arms (3)

Control group

ACTIVE COMPARATOR

control group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise)

Other: Traditional physiotherapy exercises

high-intensity laser group

EXPERIMENTAL

The high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy.

Radiation: High-Intensity laser

shock wave group

EXPERIMENTAL

shock wave (SW) group received the same intervention as the control group in addition to shock wave therapy.

Radiation: Shock Wave therapy

Interventions

intervention that lasted 3 sessions/week for 12 weeks).

high-intensity laser group

intervention that lasted 3 sessions/week for 12 weeks).

Control group

intervention that lasted 3 sessions/week for 12 weeks).

shock wave group

Eligibility Criteria

Age60 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants were diagnosed by Dual-energy X-ray absorptiometry (DEXA) as osteoporosis or osteopenia, where T-score was -1.5 or less.
  • All patients were recruited from Kasr Al-Ainy Hospital, Cairo University.

You may not qualify if:

  • BMI of more than 30 or less than 18
  • Advanced musculoskeletal disorders.
  • Rheumatoid arthritis.
  • Skin diseases.
  • Long-term steroids therapy, or any drug affecting bones.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beni-Suef University

Banī Suwayf, Sharq, 11222, Egypt

Location

Related Publications (1)

  • Abo Elyazed TI, Al-Azab IM, Abd El-Hakim AAE, Elkady SM, Afifi RMM, Obaya HE. Effect of high-intensity laser therapy versus shockwave therapy on selected outcome measures in osteoporotic long-term hemiparetic patients: a randomized control trial. J Orthop Surg Res. 2023 Sep 2;18(1):653. doi: 10.1186/s13018-023-04141-5.

MeSH Terms

Conditions

OsteoporosisHemiplegia

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Mohamed A Adel, Mr

    Beni-Suef University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass.prof

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 15, 2022

Study Start

October 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

November 15, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

IPD will be available on personal request

Locations